Paper36034697
Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout.
Wang Z and 6 others. Front Cell Infect Microbiol, 2022. Cited by 130 papers, by iCite.
Cite this record
ConductScience Library. Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout. Papers, record 36034697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36034697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gastrointestinal Microbiome | Major topic |
| Gout | Major topic |
| Hyperuricemia | Major topic |
| Probiotics | Major topic |
| Fecal Microbiota Transplantation | |
| Humans | |
| Prebiotics | |
| Purines |
Source PubMed
References133
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6681128 | A study of platelet aggregation and adhesion in gout. | Clin Exp Rheumatol | 1983 | https://conductscience.org/library/papers/6681128 | PubMed |
| 2 | 30283432 | Alterations of the Gut Microbiome Associated With the Treatment of Hyperuricaemia in Male Rats. | Front Microbiol | 2018 | https://conductscience.org/library/papers/30283432 | PubMed |
| 3 | 32134107 | Identification of the urine and serum metabolomics signature of gout. | Rheumatology (Oxford) | 2020 | https://conductscience.org/library/papers/32134107 | PubMed |
| 4 | 34505780 | Fisetin Improves Hyperuricemia-Induced Chronic Kidney Disease via Regulating Gut Microbiota-Mediated Tryptophan Metabolism and Aryl Hydrocarbon Receptor Activation. | J Agric Food Chem | 2021 | https://conductscience.org/library/papers/34505780 | PubMed |
| 5 | 33897888 | High fat diet, gut microbiome and gastrointestinal cancer. | Theranostics | 2021 | https://conductscience.org/library/papers/33897888 | PubMed |
| 6 | 24388214 | The role of short-chain fatty acids in health and disease. | Adv Immunol | 2014 | https://conductscience.org/library/papers/24388214 | PubMed |
| 7 | 30262901 | You are what you eat: diet, health and the gut microbiota. | Nat Rev Gastroenterol Hepatol | 2019 | https://conductscience.org/library/papers/30262901 | PubMed |
| 8 | 29446654 | Hypouricaemic effects of yoghurt containing Lactobacillus gasseri PA-3 in patients with hyperuricaemia and/or gout: A randomised, double-blind, placebo-controlled study. | Mod Rheumatol | 2019 | https://conductscience.org/library/papers/29446654 | PubMed |
| 9 | 31004140 | The effects of fruit consumption in patients with hyperuricaemia or gout. | Rheumatology (Oxford) | 2019 | https://conductscience.org/library/papers/31004140 | PubMed |
| 10 | 18305141 | Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. | Diabetes | 2008 | https://conductscience.org/library/papers/18305141 | PubMed |
| 11 | 33148336 | Combined effects of MSU crystals injection and high fat-diet feeding on the establishment of a gout model in C57BL/6 mice. | Adv Rheumatol | 2020 | https://conductscience.org/library/papers/33148336 | PubMed |
| 12 | 28610971 | Metabolic engineering of Escherichia coli cell factory for highly active xanthine dehydrogenase production. | Bioresour Technol | 2017 | https://conductscience.org/library/papers/28610971 | PubMed |
| 13 | 28844079 | Gout and Metabolic Syndrome: a Tangled Web. | Curr Rheumatol Rep | 2017 | https://conductscience.org/library/papers/28844079 | PubMed |
| 14 | 29408694 | Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. | J Hepatol | 2018 | https://conductscience.org/library/papers/29408694 | PubMed |
| 15 | 20202928 | Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout. | Rheumatology (Oxford) | 2010 | https://conductscience.org/library/papers/20202928 | PubMed |
| 16 | 28630380 | The Immunological Basis in the Pathogenesis of Gout. | Iran J Immunol | 2017 | https://conductscience.org/library/papers/28630380 | PubMed |
| 17 | 33798500 | Gout. | Lancet | 2021 | https://conductscience.org/library/papers/33798500 | PubMed |
| 18 | 29899272 | High-Glucose or -Fructose Diet Cause Changes of the Gut Microbiota and Metabolic Disorders in Mice without Body Weight Change. | Nutrients | 2018 | https://conductscience.org/library/papers/29899272 | PubMed |
| 19 | 30852460 | Lactobacillus brevis DM9218 ameliorates fructose-induced hyperuricemia through inosine degradation and manipulation of intestinal dysbiosis. | Nutrition | 2019 | https://conductscience.org/library/papers/30852460 | PubMed |
| 20 | 16407889 | Gout-associated uric acid crystals activate the NALP3 inflammasome. | Nature | 2006 | https://conductscience.org/library/papers/16407889 | PubMed |
Cited by96
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 130 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42948725 | Tongfengning ameliorates hyperuricemia via inhibiting gut microbiota dysbiosis-mediated TLR4/MAPK/NF-κB hyperactivation in intestinal epithelium. | Chin Herb Med | 2026 | https://conductscience.org/library/papers/42948725 | PubMed |
| 42940323 | Resveratrol Ameliorates Hyperuricemia in Association with Remodeling of the Gut Microbiota-Metabolism Axis: An Integrated 16S rDNA Sequencing and Fecal Metabolomics Study. | Foods | 2026 | https://conductscience.org/library/papers/42940323 | PubMed |
| 42877939 | Synergistic effect of a naturally derived Lactobacillus gasseri and Rumex hanus by. extract on alleviating hyperuricemia in mice via uricolysis, gut microbiota modulation, and anti-inflammation. | Biosci Microbiota Food Health | 2026 | https://conductscience.org/library/papers/42877939 | PubMed |
| 42693205 | Anti-hyperuricemia therapy alleviates diet-induced gut inflammation via AhR-IL-22-signalling. | J Mol Med (Berl) | 2026 | https://conductscience.org/library/papers/42693205 | PubMed |
| 42668570 | Gut microbiota and uric acid excretion signaling in pathogenesis of hyperuricemia and acute gouty arthritis. | iScience | 2026 | https://conductscience.org/library/papers/42668570 | PubMed |
| 42627078 | 6'‑O‑Caffeoylarbutin attenuates experimental hyperuricemia by regulating renal and intestinal urate transport, intestinal barrier integrity, and gut microbiota. | Mol Med Rep | 2026 | https://conductscience.org/library/papers/42627078 | PubMed |
| 42422989 | Association between dietary index for gut microbiota and all-cause and cardiovascular disease mortality in patients with gout and hyperuricemia: A prospective cohort study. | Sci Prog | 2026 | https://conductscience.org/library/papers/42422989 | PubMed |
| 42415877 | Biomaterial-Based Strategies for Gout Therapy: Recent Advances, Current Challenges, and Future Perspectives - A Review. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42415877 | PubMed |
| 42396658 | ABCG2 transporter: Structural and functional associations with gout (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42396658 | PubMed |
| 42376430 | Oral fungal microbiome in gout: composition, cross-kingdom interactions, and effects of intervention. | J Oral Microbiol | 2026 | https://conductscience.org/library/papers/42376430 | PubMed |
| 42353073 | The In Vivo Existence Forms of Engeletin and Their Anti-Hyperuricemia Activity. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353073 | PubMed |
| 42197271 | Cold-Adapted Uric Acid-Degrading Lacticaseibacillus paracasei NEFU-6 Application in Kimchi "Paocai". | Molecules | 2026 | https://conductscience.org/library/papers/42197271 | PubMed |
| 42157185 | Integrated multi-matrix metabolomics reveals gut microbiota-driven systemic metabolic alterations and therapeutic remodeling by fecal microbiota transplantation in autism spectrum disorder. | J Transl Med | 2026 | https://conductscience.org/library/papers/42157185 | PubMed |
| 42091940 | Urinary phytoestrogens and hyperuricemia risk in a nationally representative population: an effect modified by smoking status. | Sci Rep | 2026 | https://conductscience.org/library/papers/42091940 | PubMed |
| 42006120 | Gut microbiota: a potential therapeutic target for hyperuricemia and gout. | Biosci Microbiota Food Health | 2026 | https://conductscience.org/library/papers/42006120 | PubMed |
| 41901172 | Intestinal Multi-Target Mechanisms of Natural Active Substances in Hyperuricemia Alleviation: Recent Progress. | Nutrients | 2026 | https://conductscience.org/library/papers/41901172 | PubMed |
| 41853533 | Association of resistome abundance with hyperuricaemia in elderly individuals: a metagenomics study. | Front Microbiomes | 2024 | https://conductscience.org/library/papers/41853533 | PubMed |
| 41848409 | Oral supplementation of Pediococcus pentosaceus SMM847 ameliorates hyperuricemia in rats and alcohol-induced injury in mice. | Appl Environ Microbiol | 2026 | https://conductscience.org/library/papers/41848409 | PubMed |
| 41838319 | The Nonlinear Relationship Between Serum Uric Acid and Cardiovascular Disease Risk: Mechanistic Insights and Clinical Implications. | Cardiovasc Drugs Ther | 2026 | https://conductscience.org/library/papers/41838319 | PubMed |
| 41830551 | Gut microbiota metabolic reprogramming drives the development of metabolic diseases in the host. | Gut Microbes | 2026 | https://conductscience.org/library/papers/41830551 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCG2 | 9429 | PubTator's text mining | https://conductscience.org/library/genes/9429 | NCBI Gene |
| AOC1 | 26 | PubTator's text mining | https://conductscience.org/library/genes/26 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| RELA | 5970 | PubTator's text mining | https://conductscience.org/library/genes/5970 | NCBI Gene |
| SLC17A5 | 26503 | PubTator's text mining | https://conductscience.org/library/genes/26503 | NCBI Gene |
| SOD1 | 6647 | PubTator's text mining | https://conductscience.org/library/genes/6647 | NCBI Gene |
| XDH | 7498 | PubTator's text mining | https://conductscience.org/library/genes/7498 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36034697
GET https://conductscience.org/api/papers/v1/36034697/references?page=2